ZBTB47: A Potential Drug Target and Biomarker (G92999)

Target Name: ZBTB47

NCBI ID: G92999

ZBTB47

ZBTB47: A Potential Drug Target and Biomarker

Zinc finger and BTB domain containing 47 (ZBTB47) is a protein that has been identified as a potential drug target and biomarker. ZBTB47 is a 47kDa protein that is expressed in various tissues and cells, including brain, heart, and pancreas. It is characterized by a zinc finger and BTB domain, which give it its unique structure and function.

The zinc finger domain is a conserved region that is found in a variety of proteins, including transcription factors, DNA-binding proteins, and RNA-binding proteins. It is characterized by a specific sequence that is often found in the N-terminus of the zinc finger gene. This sequence is known as the ZNF-specific domain, and it is thought to play a role in the regulation of gene expression.

The BTB domain is a short, recovered 35 amino acid region that is located between the zinc finger domain and the N-terminus of the protein. It is characterized by a specific sequence that is often found in the C-terminus of the BTB gene . This sequence is known as the BTB-specific domain, and it is thought to play a role in the regulation of protein-protein interactions.

ZBTB47 is a protein that is expressed in the brain, heart, and pancreas, and it is characterized by a unique structure that is composed of a zinc finger domain and a BTB domain. It is thought to play a role in the regulation of various cellular processes, including cell signaling, gene expression, and protein-protein interactions.

One of the potential benefits of ZBTB47 as a drug target is its ability to modulate the activity of other proteins. For example, studies have shown that ZBTB47 can interact with the protein known as SIRT1, which is a NAD+-dependent protein that is involved in a variety of cellular processes, including DNA repair, protein folding, and stress resistance. By modulating the activity of SIRT1, ZBTB47 may be able to influence the expression of genes that are involved in stress response, aging, and other processes that are relevant to human health.

In addition to its potential as a drug target, ZBTB47 has also been identified as a potential biomarker. The ability of ZBTB47 to interact with certain proteins has led to the idea that it may be a useful biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the potential applications of ZBTB47 as a biomarker is its ability to be used as a diagnostic tool for certain diseases. For example, studies have shown that ZBTB47 is expressed in the brains of individuals with Alzheimer's disease, and that it is involved in the regulation of the expression of genes that are involved in the development and progression of this disease. This suggests that ZBTB47 may be an attractive target for diagnostic tests for Alzheimer's disease.

In addition to its potential as a drug target and biomarker, ZBTB47 is also thought to have other functions in the body. For example, studies have shown that ZBTB47 is involved in the regulation of various cellular processes, including cell signaling, gene expression, and protein-protein interactions. It is also thought to play a role in the regulation of cellular stress response, which is important for maintaining the health and function of cells.

Overall, ZBTB47 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function, as well as its involvement in various cellular processes, make it an attractive target for research and development of new therapies. Further studies are needed to fully understand the role of ZBTB47 in the regulation of cellular processes and its potential as a drug

Protein Name: Zinc Finger And BTB Domain Containing 47

Functions: May be involved in transcriptional regulation

The "ZBTB47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets